Sichuan Biokin Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sichuan Biokin Pharmaceutical Co., Ltd.

Why is Sichuan Biokin Pharmaceutical Co., Ltd. ?

The company has declared Negative results for the last 4 consecutive quarters

NET SALES(9M) At CNY 2,065.9 MM has Grown at -63.52%
NET PROFIT(9M) At CNY -500.37 MM has Grown at -112.34%
OPERATING CASH FLOW(Y) Lowest at CNY -2,331.46 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 15.04%, its profits have risen by 574%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Sichuan Biokin Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sichuan Biokin Pharmaceutical Co., Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Sichuan Biokin Pharmaceutical Co., Ltd.

-1.89%

0.40

48.39%

China Shanghai Composite

26.42%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

92.51%

EBIT Growth (5y)

-42.07%

EBIT to Interest (avg)

68.01

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.61

Tax Ratio

11.95%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2,080.57%

ROE (avg)

42.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

51.77

EV to EBIT

-65.03

EV to EBITDA

-67.87

EV to Capital Employed

51.89

EV to Sales

335.11

PEG Ratio

Dividend Yield

ROCE (Latest)

-79.78%

ROE (Latest)

-74.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -263.43% (YoY

NET SALES(Q)

Highest at CNY 1,894.7 MM

OPERATING PROFIT(Q)

Highest at CNY 948.02 MM

OPERATING PROFIT MARGIN(Q)

Highest at 50.04 %

PRE-TAX PROFIT(Q)

Highest at CNY 940.8 MM

NET PROFIT(Q)

Highest at CNY 622.43 MM

EPS(Q)

Highest at CNY 1.55

-21What is not working for the Company

NET SALES(9M)

At CNY 2,065.9 MM has Grown at -63.52%

NET PROFIT(9M)

At CNY -500.37 MM has Grown at -112.34%

OPERATING CASH FLOW(Y)

Lowest at CNY -2,331.46 MM

INTEREST(Q)

Highest at CNY 24.43 MM

Here's what is working for Sichuan Biokin Pharmaceutical Co., Ltd.

Net Sales

At CNY 1,894.7 MM has Grown at 1,625.08%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely positive

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 940.8 MM has Grown at 297.68%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 622.43 MM has Grown at 203.94%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

Highest at CNY 1,894.7 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 948.02 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 50.04 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 940.8 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 622.43 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 1.55

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -263.43% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sichuan Biokin Pharmaceutical Co., Ltd.

Interest

At CNY 24.43 MM has Grown at 32.03%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow

Lowest at CNY -2,331.46 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest

Highest at CNY 24.43 MM

in the last five periods and Increased by 32.03% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)